The motion cites 22 cases, most in California, filed against brand manufacturer Pfizer Inc. and authorized generic providers. The motion says most of the plaintiffs will be in Massachusetts or ...

The plaintiffs bar has argued that courts can only preempt prescription pharmaceutical state law failure-to-warn claims when the FDA formally rejects a proposed label change. Faced with that exact ...

A Clark County mother has filed a lawsuit against Kaiser Permanente Northwest and six of its physicians that alleges they failed to warn her daughter of the potential risk of brain tumors associated w ...

What is a meningioma and what types of injuries qualify? Depo-Provera has many known side effects. However, the current Depo-Provera litigation mainly involves a “signature injury” that was not ...

The legal landscape surrounding Depo-Provera, a long-acting injectable birth control, has entered a pivotal phase. With the growing number of lawsuits alleging that the drug caused serious brain ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

When many women turned to Depo-Provera as a convenient birth control option, they had no idea it might carry life-altering risks. After years of injections, some began experiencing troubling symptoms ...

-- Global pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection Depo-Provera (DMPA), is facing a Multidistrict Litigation (MDL No. 3140) in the USA being brought on ...

THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...

May 28, 2025 8:00 AM ETPfizer Inc. (PFE), PFE:CA Levin Papantonio is one of the leading plaintiff law firms in America. The firm has successfully represented more than 100,000 clients harmed by ...

The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...